Frontiers Dynamic immune signatures of patients with advanced non–small-cell lung cancer for infection prediction after immunotherapy

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine

Frontiers Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake

Frontiers The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients

Frontiers Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy

Frontiers The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors

Frontiers in Immunology Cancer Immunity and Immunotherapy

Frontiers T lymphocyte cell: A pivotal player in lung cancer

Pharmaceutics, Free Full-Text

Frontiers Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies

Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics

IJMS, Free Full-Text

Cancers, Free Full-Text

Frontiers Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer

Neoantigens: promising targets for cancer therapy